Background: Increased concentrations of lipoprotein (a)[Lp (a)] have been considered a
genetically determined risk factor for coronary artery and cerebrovascular disease. Only 2 …

Aims The relevance of lipoprotein (a)[Lp (a)] concentrations and low-molecular-weight
(LMW) apo (a) phenotypes in peripheral arterial disease (PAD) has only been investigated …

Abstract Serum lipoprotein (a)(Lp (a)) levels were measured in 89 men with peripheral
vascular disease (PVD) and 129 (100 male and 29 woman) healthy controls. Apolipoprotein …

Aim. Lipoprotein (a)[Lp (a)] is an independent risk factor of coronary heart disease (CHD)
and myocardial infarction. Data about the role of Lp (a) in the development of peripheral …

Abstract Background: Increased lipoprotein (a)[Lp (a)] concentrations are predictive for
coronary artery disease (CAD). The risk conferred by Lp (a) for other types of vascular …

BACKGROUND: Plasma lipoprotein (a)[Lp (a)] levels are mainly genetically determined. The
C93T polymorphism is a naturally occurring variant of the LPA gene that may influence Lp …

Plasma levels of lipoprotein [a](Lp [a]) are associated with increased risk of coronary artery
disease and show an inverse correlation with apolipoprotein [a](apo [a]) molecular weight …

Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

High lipoprotein {a)[Lp (a)] plasma concentrations, which are genetically determined by apo
(a) size polymorphism, are directly associated with an increased risk for atherosclerosis …

The serum lipoprotein (a)[Lp (a)] concentration is under genetic control, and most humans
have values lower than 30 mg/dL. Subjects with markedly elevated serum Lp (a) …